SAN DIEGO, Feb. 21, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Board of Directors has authorized a new share repurchase program under which ...
Ideaya Biosciences (IDYA) announced a research collaboration with Attmos as part of its efforts to build a physics-based computational small molecule discovery platform that unlocks what are ...
CHARLESTOWN, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for ...
SAN DIEGO, Feb. 25, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming investor conferences in March. (PRNewsfoto ...
M&T Bank Corp lifted its stake in Bruker Co. (NASDAQ:BRKR – Free Report) by 303.1% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 17,870 shares of the medical ...
Please use one of the following formats to cite this article in your essay, paper or report: APA INTEGRA Biosciences. (2025, February 14). Leveling up NGS workflows with INTEGRA Biosciences ...
SAN DIEGO, Feb. 21, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Board of Directors has authorized a new share repurchase program under which Neurocrine ...
How can a startup provide a return on investment from bringing the woolly mammoth back from the dead? Ben Lamm, the CEO and cofounder of Colossal Biosciences, the startup developing "de-extinction ...
SAN DIEGO, March 5, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) today announced the initiation of a Phase 1 clinical study to evaluate the safety, tolerability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback